Published on : Sep 16, 2016
ALBANY, New York, September 16, 2016: A recent report added to the vast market research report portfolio of ResearchMoz.us gives a detailed account of the way the present economic and business scenario will shape business confidence of the pharmaceutical industry for the second half of 2016 (from July 2016 to December 2016). The report is titled “Pharmaceutical Industry Business Confidence Report H2 2016.”
The report states that the present state of world’s economy is highly promising for the pharmaceutical industry and is expected to keep consumer confidence stable throughout the entire H2 2016. Pharmaceutical companies are optimistic about the stable economic conditions of key markets in North America and Asia Pacific and expect to gain promising returns from these regions during H2 2016. Factors such as stable domestic demand, positive growth in the U.S., and rising expenditure of government on the development of the pharmaceutical industry across emerging economies such as India and China are the key factors boosting the confidence of pharmaceutical companies in these regions.
The report states that the pharmaceutical industry will record higher expenditures in the areas of mergers and acquisitions and development of new product varieties in H2 2016 compared to the first half of the year. Moreover, a substantial rise in prices of raw material is also expected to be seen in the Europe and Asia Pacific regional markets during H2 2016 as compared to the first half of the year. The report observes that a rise by 2.5% in prices of key ingredients will be observed over the second half of the year as compared to the prices in the year’s first half across these regions.
The report also states that the economic scenario will be more favorable in Australasia and Europe during H2 2016 as compared to H1 2016. Majority of executives communicated with for gathering the data in the report are optimistic about the growth prospects of the global pharmaceutical market and its key stakeholders for the second half of 2016.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=804639
Organizations with business operations spread across Asia Pacific are more apprehensive about the development of the pharmaceutical industry across developing economies in H2 2016 as compared to the first half of the year. Owing to these concerns, companies are expected to place more focus on the development of novel product varieties and improvement of operational efficiency over the period between July 2016 and December 2016.
The report provides a detailed overview of the opinions of industry executives about the potential change in consumer confidence during H2 2016. The report also determines the way potential changes in raw material prices across various product categories will have an impact on the confidence of companies in the pharmaceutical industry during H2 2016. The report also highlights the key areas that are expected to witness highest investments across the pharmaceutical industry over H2 2016.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]